Subscribe To
PGNY / Progyny (PGNY) Q4 Earnings and Revenues Beat Estimates
PGNY News
By Seeking Alpha
October 15, 2023
Progyny: 4 Reasons I Bought This Stock
There are several clear reasons to consider Progyny stock. The company's worth is overlooked, making it a sneaky value play for investors. Here's how more_horizontal
By Zacks Investment Research
September 1, 2023
3 Reasons Growth Investors Will Love Progyny (PGNY)
Progyny (PGNY) is well positioned to outperform the market, as it exhibits above-average growth in financials. more_horizontal
By Zacks Investment Research
August 16, 2023
Here is Why Growth Investors Should Buy Progyny (PGNY) Now
Progyny (PGNY) could produce exceptional returns because of its solid growth attributes. more_horizontal
By Zacks Investment Research
August 3, 2023
Compared to Estimates, Progyny (PGNY) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Progyny (PGNY) give a sense of how the business performed in the quarter ended June 2023, it could be worth more_horizontal
By Seeking Alpha
June 29, 2023
Progyny: No Issues With Growing Healthily Ahead
Progyny: No Issues With Growing Healthily Ahead more_horizontal
By The Motley Fool
June 15, 2023
These 3 Unique Stocks Have Undeniable Long-Term Upside
A tectonic demographic shift is boosting fertility specialist Progyny. Streaming is driving massive growth for innovative demand-side ad platform The more_horizontal
By GlobeNewsWire
June 5, 2023
Progyny, Inc. to Present at Jefferies 2023 Healthcare Conference
NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family b more_horizontal
By Zacks Investment Research
May 17, 2023
Looking for a Growth Stock? 3 Reasons Why Progyny (PGNY) is a Solid Choice
Progyny (PGNY) possesses solid growth attributes, which could help it handily outperform the market. more_horizontal